Institutional investors own a significant stake of 32% in ADC Therapeutics SA (NYSE:ADCT) [Yahoo! Finance]
ADC Therapeutics SA Common Shares (ADCT)
Company Research
Source: Yahoo! Finance
The top 7 shareholders own 51% of the company Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a company If you want to know who really controls ADC Therapeutics SA ( NYSE:ADCT ), then you'll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie are institutions with 32% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn). Because institutional owners have a huge pool of resources and liquidity, their investing decisions tend to carry a great deal of weight, especially with individual investors. Hence, having a considerable amount of institutional money invested in a company is often regarded as a desirable trait. Let's take a closer look to see what the different types of shareholders can tell us about ADC Therapeutics. See our latest analysis for ADC Therapeutics Many institutions measure their
Show less
Read more
Impact Snapshot
Event Time:
ADCT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADCT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADCT alerts
High impacting ADC Therapeutics SA Common Shares news events
Weekly update
A roundup of the hottest topics
ADCT
News
- BerGenBio ASA (FRA:7BG0) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Leadership ... [Yahoo! Finance]Yahoo! Finance
- ADC Therapeutics Faces Competitive Oncology Market But Analyst Sees 100% Upside - Here's Why [Yahoo! Finance]Yahoo! Finance
- ADC Therapeutics Non-GAAP EPS of -$0.28, revenue of $18.46M misses by $0.04M [Seeking Alpha]Seeking Alpha
- ADC Therapeutics Reports Third Quarter and Year-to-Date 2024 Financial Results and Provides Operational UpdatePR Newswire
- What To Expect From ADC Therapeutics SA (ADCT) Q3 2024 Earnings [Yahoo! Finance]Yahoo! Finance
ADCT
Earnings
- 11/7/24 - Beat
ADCT
Sec Filings
- 11/14/24 - Form SC
- 11/13/24 - Form 8-K
- 11/13/24 - Form SC
- ADCT's page on the SEC website